Placebo effect on treating female sexual dysfunction

Lack of sexual arouse would be common amount female, and it was so-called sexual arousal dysfunction. But actually it would be caused by psychological issues rather then physical difficult.

Psychological issues like:

1. Bad experience: pain of vagina intercourse, lack of replay, sexual transmitted sickness, etc.

2. Emotional unavailable: work stress, dual-role like family carer and a full time worker usually took a lot of energy.

3. Value of sexuality: pregnancy, family plan, enjoyment vs practical purpose. The need of sexual life in the relationship.

4. Quality of intimate relationship: argument, fight and cold-war would affect quality of life, and sexual life would be affected as well.

5. Lack of practise: it takes time to get back to a normal sex life if there was a no-sexual-period occurred. Stress of performance.

So, if a woman is ready to take action on any type of sexual dysfunction, then it may mean the attitude is more positive and having a more supportive relationship. Maybe she would carry less psychological stress. Thus, placebo may show the effective to the person.

Counselling can help to address and overcome these psychological stress, it is a treatment option for people to choose.

....
Is there an over the counter drug that successfully treats female sexual dysfunction?

Introduction. In clinical trials of drug treatments for women's sexual dysfunction, placebo responses have often been substantial. However, little is known about the clinical significance, specificity, predictors, and potential mechanisms of placebo response in sexual dysfunction.

Results. The magnitude of change at post-treatment was clinically significant in approximately one-third of placebo recipients. Effect sizes were similar across multiple aspects of sexual function. Symptom improvement was strongly related to the frequency of satisfying sexual encounters during treatment. However, the relationship between sexual encounter frequency and outcome varied significantly between participants.

Conclusions. A substantial number of women experienced clinically significant improvement in sexual function during treatment with placebo. Changes in sexual behavior during the trial, more so than participant age or symptom severity at baseline, appeared to be an important determinant of outcome. Contextual and procedural aspects of the clinical trial may have influenced outcomes in the absence of an active drug treatment.

Source: "Behavior and Symptom Change Among Women Treated with Placebo for Sexual Dysfunction" from The Journal of Sexual Medicine, Volume 8, Issue 1, pages 191–201, January 2011